224 related articles for article (PubMed ID: 8051418)
1. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA
J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418
[TBL] [Abstract][Full Text] [Related]
2. Tenidap and other anion transport inhibitors disrupt cytolytic T lymphocyte-mediated IL-1 beta post-translational processing.
Perregaux DG; Svensson L; Gabel CA
J Immunol; 1996 Jul; 157(1):57-64. PubMed ID: 8683156
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
[TBL] [Abstract][Full Text] [Related]
4. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism.
Perregaux DG; Gabel CA
J Immunol; 1998 Mar; 160(5):2469-77. PubMed ID: 9498792
[TBL] [Abstract][Full Text] [Related]
5. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. I. Mechanism and evidence of functional significance.
McNiff P; Svensson L; Pazoles CJ; Gabel CA
J Immunol; 1994 Sep; 153(5):2180-93. PubMed ID: 8051419
[TBL] [Abstract][Full Text] [Related]
6. IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin.
Perregaux D; Barberia J; Lanzetti AJ; Geoghegan KF; Carty TJ; Gabel CA
J Immunol; 1992 Aug; 149(4):1294-303. PubMed ID: 1500719
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors.
Perregaux DG; McNiff P; Laliberte R; Hawryluk N; Peurano H; Stam E; Eggler J; Griffiths R; Dombroski MA; Gabel CA
J Pharmacol Exp Ther; 2001 Oct; 299(1):187-97. PubMed ID: 11561079
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity.
Perregaux D; Gabel CA
J Biol Chem; 1994 May; 269(21):15195-203. PubMed ID: 8195155
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.
Berkman N; John M; Roesems G; Jose PJ; Barnes PJ; Chung KF
J Immunol; 1995 Nov; 155(9):4412-8. PubMed ID: 7594602
[TBL] [Abstract][Full Text] [Related]
11. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.
Wewers MD; Rennard SI; Hance AJ; Bitterman PB; Crystal RG
J Clin Invest; 1984 Dec; 74(6):2208-18. PubMed ID: 6334697
[TBL] [Abstract][Full Text] [Related]
12. IL-1 beta-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1 beta release limitation is ICE independent.
Wewers MD; Dare HA; Winnard AV; Parker JM; Miller DK
J Immunol; 1997 Dec; 159(12):5964-72. PubMed ID: 9550394
[TBL] [Abstract][Full Text] [Related]
13. Disparate cytochemical characteristics and production of cytokines and prostaglandin E2 by human mononuclear phagocytes from the blood, lung, and peritoneal cavity.
Friedlander MA; Hilbert CM; Wu YC; Finegan CK; Rich EA
J Lab Clin Med; 1994 Apr; 123(4):574-84. PubMed ID: 8145006
[TBL] [Abstract][Full Text] [Related]
14. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response.
Sipe JD; Bartle LM; Loose LD
J Immunol; 1992 Jan; 148(2):480-4. PubMed ID: 1729367
[TBL] [Abstract][Full Text] [Related]
15. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages.
Pue CA; Mortensen RF; Marsh CB; Pope HA; Wewers MD
J Immunol; 1996 Feb; 156(4):1594-600. PubMed ID: 8568265
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
17. Tenidap-modulated proinflammatory cytokine activation of a monocyte cell line.
Golding S; Emery P; Young SP
J Immunol; 1995 May; 154(10):5384-90. PubMed ID: 7730639
[TBL] [Abstract][Full Text] [Related]
18. Human monocyte interleukin-1beta posttranslational processing. Evidence of a volume-regulated response.
Perregaux DG; Laliberte RE; Gabel CA
J Biol Chem; 1996 Nov; 271(47):29830-8. PubMed ID: 8939922
[TBL] [Abstract][Full Text] [Related]
19. Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing.
Herzyk DJ; Allen JN; Marsh CB; Wewers MD
J Immunol; 1992 Nov; 149(9):3052-8. PubMed ID: 1401931
[TBL] [Abstract][Full Text] [Related]
20. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages.
Yano S; Yanagawa H; Nishioka Y; Mukaida N; Matsushima K; Sone S
J Immunol; 1996 Sep; 157(6):2660-5. PubMed ID: 8805671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
